IkT-001Pro for Multiple Sclerosis
IkT-001Pro is a novel formulation being developed by Inhibikase Therapeutics for the treatment of progressive multifocal leukoencephalopathy (PML), one of the major complications of multiple sclerosis (MS) caused by the use of therapies that alter the immune system. How ikT-001Pro works PML is…